Theravance Biopharma Expands in Ireland
3rd November 2017
Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma”) has announced the opening of a new corporate office in Dublin, further establishing the Company’s presence in Ireland.
The Company plans to expand its Dublin employee base by hiring 30 highly-skilled professionals over the next two years in in areas such as clinical development, finance, and technical operations.
An Tánaiste and Minister for Business, Enterprise and Innovation Frances Fitzgerald TD and other IDA Ireland executives joined members of the Theravance Biopharma board of directors and employees at the opening ceremony. “The opening of our new office in Dublin demonstrates the increasingly important role that Theravance Biopharma plays in the global biopharmaceutical business, as we work with purpose to translate our science into therapeutics that can help patients around the world,” said Rick E Winningham, Chairman and Chief Executive Officer.
Dr. Ann Brady, President, Theravance Biopharma Ireland commented: “This important expansion within Ireland provides an opportunity to tap into the extensive biopharmaceutical talent pool within the country. Our Irish team looks forward to helping to build on Theravance Biopharma’s legacy of scientific expertise, advance our pipeline of potential therapies in multiple disease areas, and ultimately change the way serious diseases are treated.”
“The pharmaceutical industry makes a huge contribution to the Irish economy in terms of jobs and manufacturing exports, and is one of our fastest growing sectors,” said An Tánaiste, Frances Fitzgerald. “My department through IDA Ireland is keen to attract new dynamic pharmaceutical companies like Theravance Biopharma who will broaden the reach of the industry here and generate new opportunities. I look forward to a mutually beneficial partnership developing.”
“Theravance Biopharma is a very welcome addition to the biopharmaceutical operations in Ireland who have established highly specialized technical, financial and commercial operations throughout the country,” said Mary Buckley, Executive Director, IDA Ireland. “IDA Ireland looks forward to the Company’s further growth over the coming years.”
(Pictured L-R: Dr. Ann Brady, President, Theravance Biopharma Ireland, An Tánaiste, Frances Fitzgerald, Rick E Winningham, Chairman and Chief Executive Officer and Mary Buckley, Executive Director, IDA Ireland).
